Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	neurohypophyseal hormone activity	OXT AVP	3.34e-06	2	37	2	GO:0005185
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	EPHB4 ERBB2 ERBB3 TIE1	6.23e-06	65	37	4	GO:0004714
GeneOntologyMolecularFunction	V1A vasopressin receptor binding	OXT AVP	1.00e-05	3	37	2	GO:0031894
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	EPHB4 ERBB2 ERBB3 TIE1	1.81e-05	85	37	4	GO:0019199
GeneOntologyMolecularFunction	vasopressin receptor binding	OXT AVP	2.00e-05	4	37	2	GO:0031893
GeneOntologyMolecularFunction	extracellular matrix structural constituent	LAMA5 CRELD1 LAMC2 SSPOP TNC	2.39e-05	188	37	5	GO:0005201
GeneOntologyMolecularFunction	ErbB-3 class receptor binding	ERBB2 ERBB3	4.99e-05	6	37	2	GO:0043125
GeneOntologyMolecularFunction	protein tyrosine kinase activity	EPHB4 ERBB2 ERBB3 TIE1	1.46e-04	145	37	4	GO:0004713
GeneOntologyMolecularFunction	complement component C1q complex binding	C1QBP MEGF10	1.49e-04	10	37	2	GO:0001849
GeneOntologyMolecularFunction	integrin binding	LAMA5 TNC SVEP1 EGFL6	3.00e-04	175	37	4	GO:0005178
GeneOntologyMolecularFunction	Wnt receptor activity	FZD8 PKD1	4.46e-04	17	37	2	GO:0042813
GeneOntologyMolecularFunction	opsonin binding	C1QBP MEGF10	9.76e-04	25	37	2	GO:0001846
GeneOntologyMolecularFunction	scavenger receptor activity	MEGF10 STAB1	1.14e-03	27	37	2	GO:0005044
GeneOntologyMolecularFunction	hyaluronic acid binding	C1QBP STAB1	1.31e-03	29	37	2	GO:0005540
GeneOntologyMolecularFunction	complement binding	C1QBP MEGF10	1.60e-03	32	37	2	GO:0001848
GeneOntologyMolecularFunction	neuropeptide hormone activity	OXT AVP	1.81e-03	34	37	2	GO:0005184
GeneOntologyMolecularFunction	neuropeptide activity	OXT AVP	1.81e-03	34	37	2	GO:0160041
GeneOntologyMolecularFunction	Wnt-protein binding	FZD8 WIF1	1.81e-03	34	37	2	GO:0017147
GeneOntologyMolecularFunction	protein kinase activity	EPHB4 ERBB2 ERBB3 TIE1 AVP	4.74e-03	600	37	5	GO:0004672
GeneOntologyBiologicalProcess	branching involved in lymph vessel morphogenesis	TIE1 PKD1	8.38e-06	3	35	2	GO:0060854
GeneOntologyBiologicalProcess	grooming behavior	KCNQ2 OXT AVP	8.84e-06	24	35	3	GO:0007625
GeneOntologyBiologicalProcess	lymph vessel morphogenesis	TIE1 SVEP1 PKD1	8.84e-06	24	35	3	GO:0036303
GeneOntologyBiologicalProcess	circulatory system development	EPHB4 FZD8 CRELD1 ERBB2 ERBB3 OXT TIE1 SVEP1 WIF1 STAB1 PKD1	1.63e-05	1442	35	11	GO:0072359
GeneOntologyBiologicalProcess	maternal aggressive behavior	OXT AVP	1.67e-05	4	35	2	GO:0002125
GeneOntologyBiologicalProcess	regulation of cell adhesion	EPHB4 C1QBP LAMA5 ERBB2 ERBB3 TNC MEGF10 EGFL6 PKD1	1.77e-05	927	35	9	GO:0030155
GeneOntologyBiologicalProcess	lymph vessel development	TIE1 SVEP1 PKD1	2.15e-05	32	35	3	GO:0001945
GeneOntologyBiologicalProcess	heart development	EPHB4 CRELD1 ERBB2 ERBB3 OXT TIE1 WIF1 PKD1	3.10e-05	757	35	8	GO:0007507
GeneOntologyBiologicalProcess	regulation of female receptivity	OXT AVP	1.00e-04	9	35	2	GO:0045924
GeneOntologyBiologicalProcess	vasculature development	EPHB4 FZD8 ERBB2 TIE1 SVEP1 WIF1 STAB1 PKD1	1.75e-04	969	35	8	GO:0001944
GeneOntologyBiologicalProcess	female mating behavior	OXT AVP	1.83e-04	12	35	2	GO:0060180
GeneOntologyBiologicalProcess	aggressive behavior	OXT AVP	2.16e-04	13	35	2	GO:0002118
GeneOntologyBiologicalProcess	ERBB2-ERBB3 signaling pathway	ERBB2 ERBB3	2.16e-04	13	35	2	GO:0038133
GeneOntologyBiologicalProcess	ERBB3 signaling pathway	ERBB2 ERBB3	2.51e-04	14	35	2	GO:0038129
GeneOntologyBiologicalProcess	social behavior	KCNQ2 OXT AVP	2.67e-04	74	35	3	GO:0035176
GeneOntologyBiologicalProcess	biological process involved in intraspecies interaction between organisms	KCNQ2 OXT AVP	2.89e-04	76	35	3	GO:0051703
GeneOntologyBiologicalProcess	branching morphogenesis of an epithelial tube	LAMA5 TIE1 TNC PKD1	3.42e-04	198	35	4	GO:0048754
GeneOntologyBiologicalProcess	maternal behavior	OXT AVP	4.21e-04	18	35	2	GO:0042711
GeneOntologyBiologicalProcess	tube morphogenesis	EPHB4 FZD8 LAMA5 ERBB2 TIE1 TNC STAB1 PKD1	4.80e-04	1125	35	8	GO:0035239
GeneOntologyBiologicalProcess	positive regulation of kinase activity	EPHB4 FZD8 ERBB2 ERBB3 TIE1	5.69e-04	405	35	5	GO:0033674
GeneOntologyBiologicalProcess	lymphangiogenesis	TIE1 PKD1	5.76e-04	21	35	2	GO:0001946
GeneOntologyBiologicalProcess	parental behavior	OXT AVP	5.76e-04	21	35	2	GO:0060746
GeneOntologyBiologicalProcess	cell-substrate adhesion	C1QBP LAMA5 SVEP1 EGFL6 PKD1	6.01e-04	410	35	5	GO:0031589
GeneOntologyBiologicalProcess	morphogenesis of a branching epithelium	LAMA5 TIE1 TNC PKD1	6.62e-04	236	35	4	GO:0061138
GeneOntologyBiologicalProcess	blood vessel development	EPHB4 FZD8 ERBB2 TIE1 WIF1 STAB1 PKD1	8.17e-04	929	35	7	GO:0001568
GeneOntologyBiologicalProcess	transmission of nerve impulse	KCNQ2 CLCN1 AVP	8.99e-04	112	35	3	GO:0019226
GeneOntologyBiologicalProcess	morphogenesis of a branching structure	LAMA5 TIE1 TNC PKD1	9.23e-04	258	35	4	GO:0001763
GeneOntologyBiologicalProcess	ERBB2 signaling pathway	ERBB2 ERBB3	9.56e-04	27	35	2	GO:0038128
GeneOntologyBiologicalProcess	regulation of complement activation	C1QBP SVEP1	9.56e-04	27	35	2	GO:0030449
GeneOntologyCellularComponent	ERBB3:ERBB2 complex	ERBB2 ERBB3	3.05e-06	2	37	2	GO:0038143
GeneOntologyCellularComponent	extracellular matrix	LAMA5 CRELD1 LAMC2 FCGBP SSPOP TNC SVEP1 EGFL6	1.55e-05	656	37	8	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	LAMA5 CRELD1 LAMC2 FCGBP SSPOP TNC SVEP1 EGFL6	1.59e-05	658	37	8	GO:0030312
GeneOntologyCellularComponent	laminin-5 complex	LAMA5 LAMC2	1.82e-05	4	37	2	GO:0005610
GeneOntologyCellularComponent	basement membrane	LAMA5 LAMC2 TNC EGFL6	6.28e-05	122	37	4	GO:0005604
GeneOntologyCellularComponent	laminin complex	LAMA5 LAMC2	1.36e-04	10	37	2	GO:0043256
GeneOntologyCellularComponent	synapse-associated extracellular matrix	LAMA5 TNC	2.35e-04	13	37	2	GO:0099535
GeneOntologyCellularComponent	collagen-containing extracellular matrix	LAMA5 CRELD1 LAMC2 SSPOP TNC EGFL6	3.08e-04	530	37	6	GO:0062023
GeneOntologyCellularComponent	membrane protein complex	FZD8 KCNQ2 ERBB2 ERBB3 ANKFY1 CLCN1 SSPOP SOCS7 PKD1	9.65e-04	1498	37	9	GO:0098796
GeneOntologyCellularComponent	neuronal dense core vesicle	FZD8 AVP	1.85e-03	36	37	2	GO:0098992
GeneOntologyCellularComponent	dense core granule	FZD8 AVP	4.42e-03	56	37	2	GO:0031045
MousePheno	decreased atrioventricular cushion size	CRELD1 ERBB2 ERBB3	6.41e-06	18	29	3	MP:0000301
MousePheno	abnormal Schwann cell precursor morphology	ERBB2 ERBB3	1.25e-05	3	29	2	MP:0004074
MousePheno	decreased Schwann cell precursor number	ERBB2 ERBB3	1.25e-05	3	29	2	MP:0004075
MousePheno	abnormal atrioventricular cushion morphology	CRELD1 ERBB2 ERBB3 PKD1	1.73e-05	76	29	4	MP:0000297
MousePheno	megacephaly	LAMA5 KCNQ2 SOCS7	1.79e-05	25	29	3	MP:0000434
MousePheno	abnormal fetal atrioventricular canal morphology	CRELD1 ERBB2 ERBB3 PKD1	2.23e-05	81	29	4	MP:0006107
MousePheno	lethality during fetal growth through weaning, complete penetrance	LAMA5 KCNQ2 LAMC2 ERBB2 ERBB3 ECEL1 TIE1 AVP SOCS7 PKD1	1.47e-04	1269	29	10	MP:0011111
MousePheno	skin edema	TIE1 SVEP1 PKD1	1.75e-04	53	29	3	MP:0001786
MousePheno	abnormal myocardial trabeculae morphology	EPHB4 ERBB2 ERBB3 PKD1	2.10e-04	144	29	4	MP:0002189
MousePheno	abnormal phrenic nerve innervation pattern to diaphragm	ERBB2 ECEL1	2.26e-04	11	29	2	MP:0012055
MousePheno	abnormal phrenic nerve innervation pattern	ERBB2 ECEL1	2.26e-04	11	29	2	MP:0012054
MousePheno	abnormal epidermal-dermal junction morphology	LAMA5 LAMC2	2.71e-04	12	29	2	MP:0011159
MousePheno	respiratory failure	ERBB2 ERBB3 ECEL1 TIE1	3.53e-04	165	29	4	MP:0001953
MousePheno	abnormal petrosal ganglion morphology	ERBB2 ERBB3	3.72e-04	14	29	2	MP:0001084
MousePheno	decreased respiration	ERBB2 ERBB3 ECEL1 TIE1	3.95e-04	170	29	4	MP:0014274
MousePheno	abnormal lymphangiogenesis	TIE1 SVEP1	4.29e-04	15	29	2	MP:0008778
MousePheno	poor circulation	ERBB2 ERBB3	6.95e-04	19	29	2	MP:0001633
MousePheno	abnormal ventral spinal root morphology	ERBB2 ERBB3	6.95e-04	19	29	2	MP:0003993
Domain	Growth_fac_rcpt_	EPHB4 LAMA5 CRELD1 LAMC2 ERBB2 ERBB3 TIE1 TNC SVEP1 EGFL6 STAB1	6.85e-15	156	37	11	IPR009030
Domain	EGF_2	EPHB4 LAMA5 CRELD1 LAMC2 TIE1 SSPOP TNC SVEP1 MEGF10 EGFL6 WIF1 STAB1	7.02e-14	265	37	12	PS01186
Domain	EGF	LAMA5 CRELD1 LAMC2 FCGBP TIE1 TNC SVEP1 MEGF10 EGFL6 WIF1 STAB1	6.35e-13	235	37	11	SM00181
Domain	EGF-like_dom	LAMA5 CRELD1 LAMC2 FCGBP TIE1 TNC SVEP1 MEGF10 EGFL6 WIF1 STAB1	1.19e-12	249	37	11	IPR000742
Domain	EGF_1	LAMA5 CRELD1 LAMC2 TIE1 SSPOP TNC SVEP1 MEGF10 EGFL6 WIF1 STAB1	1.55e-12	255	37	11	PS00022
Domain	EGF-like_CS	EPHB4 LAMA5 CRELD1 LAMC2 TIE1 TNC SVEP1 MEGF10 EGFL6 WIF1 STAB1	1.99e-12	261	37	11	IPR013032
Domain	EGF_3	CRELD1 TIE1 SSPOP TNC SVEP1 MEGF10 EGFL6 WIF1 STAB1	6.21e-10	235	37	9	PS50026
Domain	EGF_extracell	TIE1 TNC SVEP1 MEGF10 WIF1 STAB1	1.83e-09	60	37	6	IPR013111
Domain	EGF_2	TIE1 TNC SVEP1 MEGF10 WIF1 STAB1	1.83e-09	60	37	6	PF07974
Domain	Laminin_EGF	LAMA5 CRELD1 LAMC2 MEGF10 STAB1	7.16e-09	35	37	5	PF00053
Domain	Laminin_EGF	LAMA5 CRELD1 LAMC2 MEGF10 STAB1	1.10e-08	38	37	5	IPR002049
Domain	EGF_Lam	LAMA5 LAMC2 MEGF10 STAB1	6.53e-07	35	37	4	SM00180
Domain	-	SVEP1 EGFL6 STAB1	1.17e-06	11	37	3	2.40.155.10
Domain	GFP-like	SVEP1 EGFL6 STAB1	1.17e-06	11	37	3	IPR023413
Domain	Neurhyp_horm	OXT AVP	3.82e-06	2	37	2	PD001676
Domain	Neurohypophysial_hormone_CS	OXT AVP	3.82e-06	2	37	2	IPR022423
Domain	Hormone_4	OXT AVP	3.82e-06	2	37	2	PF00220
Domain	Hormone_5	OXT AVP	3.82e-06	2	37	2	PF00184
Domain	-	OXT AVP	3.82e-06	2	37	2	2.60.9.10
Domain	NEUROHYPOPHYS_HORM	OXT AVP	3.82e-06	2	37	2	PS00264
Domain	NH	OXT AVP	3.82e-06	2	37	2	SM00003
Domain	EGF	TIE1 TNC SVEP1 WIF1 STAB1	4.73e-06	126	37	5	PF00008
Domain	Furin_repeat	CRELD1 ERBB2 ERBB3	5.72e-06	18	37	3	IPR006212
Domain	FU	CRELD1 ERBB2 ERBB3	5.72e-06	18	37	3	SM00261
Domain	hEGF	SVEP1 MEGF10 WIF1	2.27e-05	28	37	3	PF12661
Domain	Neurhyp_horm	OXT AVP	2.29e-05	4	37	2	IPR000981
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB2 ERBB3	2.29e-05	4	37	2	IPR016245
Domain	TyrKc	EPHB4 ERBB2 ERBB3 TIE1	2.70e-05	88	37	4	SM00219
Domain	Tyr_kinase_cat_dom	EPHB4 ERBB2 ERBB3 TIE1	2.70e-05	88	37	4	IPR020635
Domain	EGF_LAM_2	LAMA5 LAMC2 STAB1	2.80e-05	30	37	3	PS50027
Domain	EGF_LAM_1	LAMA5 LAMC2 STAB1	2.80e-05	30	37	3	PS01248
Domain	PROTEIN_KINASE_TYR	EPHB4 ERBB2 ERBB3 TIE1	3.96e-05	97	37	4	PS00109
Domain	Tyr_kinase_AS	EPHB4 ERBB2 ERBB3 TIE1	3.96e-05	97	37	4	IPR008266
Domain	GF_recep_IV	ERBB2 ERBB3	5.70e-05	6	37	2	PF14843
Domain	GF_recep_IV	ERBB2 ERBB3	5.70e-05	6	37	2	IPR032778
Domain	Furin-like	ERBB2 ERBB3	7.97e-05	7	37	2	PF00757
Domain	Rcpt_L-dom	ERBB2 ERBB3	7.97e-05	7	37	2	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB2 ERBB3	7.97e-05	7	37	2	IPR006211
Domain	Recep_L_domain	ERBB2 ERBB3	7.97e-05	7	37	2	PF01030
Domain	-	ERBB2 ERBB3	7.97e-05	7	37	2	3.80.20.20
Domain	EGF_CA	CRELD1 SVEP1 EGFL6 STAB1	9.69e-05	122	37	4	SM00179
Domain	EGF-like_Ca-bd_dom	CRELD1 SVEP1 EGFL6 STAB1	1.03e-04	124	37	4	IPR001881
Domain	LAMININ_IVA	LAMA5 LAMC2	1.06e-04	8	37	2	PS51115
Domain	Laminin_B	LAMA5 LAMC2	1.06e-04	8	37	2	PF00052
Domain	LamB	LAMA5 LAMC2	1.06e-04	8	37	2	SM00281
Domain	Laminin_IV	LAMA5 LAMC2	1.06e-04	8	37	2	IPR000034
Domain	Pkinase_Tyr	EPHB4 ERBB2 ERBB3 TIE1	1.20e-04	129	37	4	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	EPHB4 ERBB2 ERBB3 TIE1	1.56e-04	138	37	4	IPR001245
Domain	Ephrin_rec_like	EPHB4 SVEP1	2.08e-04	11	37	2	PF07699
Domain	TIL	FCGBP SSPOP	2.49e-04	12	37	2	PF01826
Domain	C8	FCGBP SSPOP	2.49e-04	12	37	2	PF08742
Domain	Unchr_dom_Cys-rich	FCGBP SSPOP	2.94e-04	13	37	2	IPR014853
Domain	C8	FCGBP SSPOP	2.94e-04	13	37	2	SM00832
Domain	TIL_dom	FCGBP SSPOP	3.42e-04	14	37	2	IPR002919
Domain	VWD	FCGBP SSPOP	4.50e-04	16	37	2	SM00216
Domain	VWF_type-D	FCGBP SSPOP	4.50e-04	16	37	2	IPR001846
Domain	VWFD	FCGBP SSPOP	4.50e-04	16	37	2	PS51233
Domain	VWD	FCGBP SSPOP	4.50e-04	16	37	2	PF00094
Domain	EMI	SSPOP MEGF10	5.10e-04	17	37	2	PS51041
Domain	VWC_out	FCGBP SSPOP	6.39e-04	19	37	2	SM00215
Domain	EGF_CA	CRELD1 SVEP1 EGFL6	6.54e-04	86	37	3	PF07645
Domain	Galactose-bd-like	EPHB4 LAMA5 SSPOP	8.47e-04	94	37	3	IPR008979
Domain	EGF_Ca-bd_CS	CRELD1 SVEP1 EGFL6	9.28e-04	97	37	3	IPR018097
Domain	EGF_CA	CRELD1 SVEP1 EGFL6	9.85e-04	99	37	3	PS01187
Domain	ASX_HYDROXYL	CRELD1 SVEP1 EGFL6	1.01e-03	100	37	3	PS00010
Domain	Ephrin_rec_like	EPHB4 SVEP1	1.11e-03	25	37	2	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB4 SVEP1	1.11e-03	25	37	2	IPR011641
Domain	EGF-type_Asp/Asn_hydroxyl_site	CRELD1 SVEP1 EGFL6	1.20e-03	106	37	3	IPR000152
Domain	VWC	FCGBP SSPOP	2.57e-03	38	37	2	SM00214
Domain	VWF_dom	FCGBP SSPOP	3.13e-03	42	37	2	IPR001007
Domain	L_dom-like	FBXL17 ERBB2 ERBB3 PKD1	3.91e-03	328	37	4	IPR032675
Domain	fn3	EPHB4 TIE1 TNC	4.01e-03	162	37	3	PF00041
Domain	LDLRA_1	SSPOP PKD1	4.07e-03	48	37	2	PS01209
Domain	LDLRA_2	SSPOP PKD1	4.24e-03	49	37	2	PS50068
Domain	FN3	EPHB4 TIE1 TNC	5.80e-03	185	37	3	SM00060
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	LAMA5 LAMC2 ERBB2 ERBB3	1.65e-06	46	27	4	M239
Pathway	REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB3	3.52e-05	5	27	2	M26937
Pathway	REACTOME_VASOPRESSIN_LIKE_RECEPTORS	OXT AVP	5.27e-05	6	27	2	M27289
Pathway	REACTOME_VASOPRESSIN_LIKE_RECEPTORS	OXT AVP	5.27e-05	6	27	2	MM14989
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	LAMA5 LAMC2 TNC	1.90e-04	59	27	3	M27218
Pathway	PID_INTEGRIN4_PATHWAY	LAMA5 LAMC2	1.92e-04	11	27	2	M158
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB2 ERBB3	1.92e-04	11	27	2	MM15478
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	ERBB2 ERBB3	2.30e-04	12	27	2	MM14550
Pathway	WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY	LAMA5 LAMC2 ERBB2	2.65e-04	66	27	3	MM15925
Pathway	PID_INTEGRIN1_PATHWAY	LAMA5 LAMC2 TNC	2.65e-04	66	27	3	M18
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	ERBB2 ERBB3	2.72e-04	13	27	2	M549
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB2 ERBB3	2.72e-04	13	27	2	M27729
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB2 ERBB3	2.72e-04	13	27	2	MM15320
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB3	3.17e-04	14	27	2	MM14761
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB3	3.17e-04	14	27	2	MM14531
Pathway	PID_ERBB_NETWORK_PATHWAY	ERBB2 ERBB3	3.65e-04	15	27	2	M201
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB2 ERBB3	3.65e-04	15	27	2	M27608
Pathway	WP_FOCAL_ADHESION	LAMA5 LAMC2 ERBB2 TNC	4.14e-04	187	27	4	MM15913
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB3	4.17e-04	16	27	2	M570
Pathway	WP_FOCAL_ADHESION	LAMA5 LAMC2 ERBB2 TNC	5.24e-04	199	27	4	M39402
Pathway	KEGG_FOCAL_ADHESION	LAMA5 LAMC2 ERBB2 TNC	5.24e-04	199	27	4	M7253
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	LAMA5 LAMC2 TNC	5.38e-04	84	27	3	M7098
Pathway	WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY	FZD8 ERBB2 PKD1	5.57e-04	85	27	3	M48315
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB3	7.97e-04	22	27	2	M26929
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB3	8.72e-04	23	27	2	MM1480
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB3	8.72e-04	23	27	2	M18719
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	ERBB2 ERBB3	1.03e-03	25	27	2	M47934
Pathway	REACTOME_SIGNALING_BY_ERBB2_IN_CANCER	ERBB2 ERBB3	1.12e-03	26	27	2	M29535
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	ERBB2 ERBB3	1.12e-03	26	27	2	MM15501
Pathway	PID_WNT_SIGNALING_PATHWAY	FZD8 WIF1	1.29e-03	28	27	2	M77
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	ERBB2 ERBB3	1.39e-03	29	27	2	M27756
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	LAMA5 LAMC2	1.49e-03	30	27	2	M27772
Pathway	REACTOME_LAMININ_INTERACTIONS	LAMA5 LAMC2	1.49e-03	30	27	2	M27216
Pathway	WP_INFLAMMATORY_RESPONSE_PATHWAY	LAMA5 LAMC2	1.49e-03	30	27	2	M39641
Pathway	WP_INFLAMMATORY_RESPONSE_PATHWAY	LAMA5 LAMC2	1.49e-03	30	27	2	MM15812
Pathway	WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4	ERBB2 ERBB3	1.80e-03	33	27	2	M39455
Pathway	WP_ALPHA_6_BETA_4_SIGNALING	LAMA5 LAMC2	1.80e-03	33	27	2	M39503
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	LAMA5 LAMC2	2.77e-03	41	27	2	M27778
Pathway	PID_ERBB2_ERBB3_PATHWAY	ERBB2 ERBB3	3.18e-03	44	27	2	M175
Pathway	REACTOME_SIGNALING_BY_ERBB2	ERBB2 ERBB3	3.18e-03	44	27	2	MM14520
Pathway	KEGG_PATHWAYS_IN_CANCER	FZD8 LAMA5 LAMC2 ERBB2	3.20e-03	325	27	4	M12868
Pathway	PID_PS1_PATHWAY	SSPOP WIF1	3.47e-03	46	27	2	M70
Pathway	WP_ERBB_SIGNALING_PATHWAY	ERBB2 ERBB3	3.47e-03	46	27	2	MM15950
Pathway	PID_FANCONI_PATHWAY	FAAP100 SSPOP	3.62e-03	47	27	2	M1
Pathway	REACTOME_SIGNALING_BY_PTK6	ERBB2 ERBB3	3.77e-03	48	27	2	MM15479
Pathway	REACTOME_SIGNALING_BY_ERBB2	ERBB2 ERBB3	4.09e-03	50	27	2	M553
Pathway	REACTOME_SIGNALING_BY_PTK6	ERBB2 ERBB3	4.75e-03	54	27	2	M29742
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	ERBB2 ERBB3	4.93e-03	55	27	2	M47952
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPHB4 ZXDC LAMA5 KCNQ2 ERBB2 RAPGEF6 ZNF865 FAAP100 TMC6 PKD1	2.12e-07	1105	38	10	35748872
Pubmed	Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.	LAMA5 TIE1 SVEP1	6.67e-07	16	38	3	28179430
Pubmed	H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.	ERBB2 ERBB3	1.16e-06	2	38	2	20581867
Pubmed	Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers.	ERBB2 ERBB3	1.16e-06	2	38	2	35108525
Pubmed	Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	17203234
Pubmed	Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.	ERBB2 ERBB3	1.16e-06	2	38	2	22733765
Pubmed	Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons.	OXT AVP	1.16e-06	2	38	2	22262306
Pubmed	The neurohypophyseal hormones vasopressin and oxytocin. Precursor structure, synthesis and regulation.	OXT AVP	1.16e-06	2	38	2	3768139
Pubmed	Expression of the vasopressin and oxytocin genes in human hypothalami.	OXT AVP	1.16e-06	2	38	2	4065330
Pubmed	The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line.	OXT AVP	1.16e-06	2	38	2	2991279
Pubmed	Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.	ERBB2 ERBB3	1.16e-06	2	38	2	16199884
Pubmed	Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	30068375
Pubmed	HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.	ERBB2 ERBB3	1.16e-06	2	38	2	25739551
Pubmed	Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy.	ERBB2 ERBB3	1.16e-06	2	38	2	38441358
Pubmed	Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.	OXT AVP	1.16e-06	2	38	2	29609987
Pubmed	Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	10205169
Pubmed	A systematic survey of the intergenic region between the murine oxytocin- and vasopressin-encoding genes.	OXT AVP	1.16e-06	2	38	2	8863731
Pubmed	In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	21638049
Pubmed	Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.	ERBB2 ERBB3	1.16e-06	2	38	2	17638894
Pubmed	Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage.	OXT AVP	1.16e-06	2	38	2	24412107
Pubmed	Synthesis, transport, and release of posterior pituitary hormones.	OXT AVP	1.16e-06	2	38	2	6153132
Pubmed	The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	27317872
Pubmed	The contributions of oxytocin and vasopressin pathway genes to human behavior.	OXT AVP	1.16e-06	2	38	2	22245314
Pubmed	The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.	ERBB2 ERBB3	1.16e-06	2	38	2	12853564
Pubmed	Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.	ERBB2 ERBB3	1.16e-06	2	38	2	21709195
Pubmed	Mothers of autistic children: lower plasma levels of oxytocin and Arg-vasopressin and a higher level of testosterone.	OXT AVP	1.16e-06	2	38	2	24086383
Pubmed	Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors.	ERBB2 ERBB3	1.16e-06	2	38	2	12134143
Pubmed	Higher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers.	ERBB2 ERBB3	1.16e-06	2	38	2	18942860
Pubmed	Influence of perioperative stress on central and peripheral oxytocin and arginine-vasopressin concentrations.	OXT AVP	1.16e-06	2	38	2	31538678
Pubmed	The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers.	ERBB2 ERBB3	1.16e-06	2	38	2	33907275
Pubmed	Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	22848366
Pubmed	A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.	ERBB2 ERBB3	1.16e-06	2	38	2	18056992
Pubmed	HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	25915155
Pubmed	Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions.	OXT AVP	1.16e-06	2	38	2	23589638
Pubmed	[Oxytocin and vasopressin: sexual differences and clinical implications].	OXT AVP	1.16e-06	2	38	2	37200960
Pubmed	Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.	ERBB2 ERBB3	1.16e-06	2	38	2	25017122
Pubmed	Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3.	ERBB2 ERBB3	1.16e-06	2	38	2	23698633
Pubmed	Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree.	OXT AVP	1.16e-06	2	38	2	21899794
Pubmed	The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.	ERBB2 ERBB3	1.16e-06	2	38	2	35177646
Pubmed	Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.	ERBB2 ERBB3	1.16e-06	2	38	2	7538656
Pubmed	Pharmacological targeting of the pseudokinase Her3.	ERBB2 ERBB3	1.16e-06	2	38	2	25326665
Pubmed	Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients.	ERBB2 ERBB3	1.16e-06	2	38	2	26208475
Pubmed	On the nature of oxytocin and vasopressin from human pituitary.	OXT AVP	1.16e-06	2	38	2	13591312
Pubmed	Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.	ERBB2 ERBB3	1.16e-06	2	38	2	29959202
Pubmed	HER2 expression as a potential marker for response to therapy targeted to the EGFR.	ERBB2 ERBB3	1.16e-06	2	38	2	16622439
Pubmed	ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival.	ERBB2 ERBB3	1.16e-06	2	38	2	22157714
Pubmed	Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.	ERBB2 ERBB3	1.16e-06	2	38	2	31932682
Pubmed	Early response to ErbB2 over-expression in polarized Caco-2 cells involves partial segregation from ErbB3 by relocalization to the apical surface and initiation of survival signaling.	ERBB2 ERBB3	1.16e-06	2	38	2	20589763
Pubmed	Neuregulin induces the rapid association of focal adhesion kinase with the erbB2-erbB3 receptor complex in schwann cells.	ERBB2 ERBB3	1.16e-06	2	38	2	10799311
Pubmed	Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.	ERBB2 ERBB3	1.16e-06	2	38	2	22806884
Pubmed	Marital behavior, oxytocin, vasopressin, and wound healing.	OXT AVP	1.16e-06	2	38	2	20144509
Pubmed	Medial amygdala lesions modify aggressive behavior and immediate early gene expression in oxytocin and vasopressin neurons during intermale exposure.	OXT AVP	1.16e-06	2	38	2	23403283
Pubmed	Oncogenic ERBB3 mutations in human cancers.	ERBB2 ERBB3	1.16e-06	2	38	2	23680147
Pubmed	Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface.	ERBB2 ERBB3	1.16e-06	2	38	2	23843458
Pubmed	Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.	ERBB2 ERBB3	1.16e-06	2	38	2	34171264
Pubmed	Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domain.	ERBB2 ERBB3	1.16e-06	2	38	2	23688700
Pubmed	HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways.	ERBB2 ERBB3	1.16e-06	2	38	2	22983903
Pubmed	HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.	ERBB2 ERBB3	1.16e-06	2	38	2	27358485
Pubmed	Expression of the arginine vasopressin gene in response to salt loading in oxytocin gene knockout mice.	OXT AVP	1.16e-06	2	38	2	14962074
Pubmed	Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro.	OXT AVP	1.16e-06	2	38	2	12944509
Pubmed	Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase.	ERBB2 ERBB3	1.16e-06	2	38	2	21385943
Pubmed	CRISPR-assisted receptor deletion reveals distinct roles for ERBB2 and ERBB3 in skin keratinocytes.	ERBB2 ERBB3	1.16e-06	2	38	2	28805349
Pubmed	Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association.	ERBB2 ERBB3	1.16e-06	2	38	2	12000754
Pubmed	Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.	ERBB2 ERBB3	1.16e-06	2	38	2	22248472
Pubmed	Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder.	OXT AVP	1.16e-06	2	38	2	19500216
Pubmed	Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.	OXT AVP	1.16e-06	2	38	2	36113782
Pubmed	Defensive behavioral strategies and enhanced state anxiety during chronic subordinate colony housing are accompanied by reduced hypothalamic vasopressin, but not oxytocin, expression.	OXT AVP	1.16e-06	2	38	2	19120108
Pubmed	Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea.	ERBB2 ERBB3	1.16e-06	2	38	2	12483526
Pubmed	Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation.	ERBB2 ERBB3	1.16e-06	2	38	2	12888923
Pubmed	The Role of Oxytocin and Vasopressin in Drug-Induced Reward-Implications for Social and Non-Social Factors.	OXT AVP	1.16e-06	2	38	2	36979340
Pubmed	Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.	ERBB2 ERBB3	1.16e-06	2	38	2	25112701
Pubmed	Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.	ERBB2 ERBB3	1.16e-06	2	38	2	14737100
Pubmed	Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice.	ERBB2 ERBB3	1.16e-06	2	38	2	15731393
Pubmed	Identification of human neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins.	OXT AVP	1.16e-06	2	38	2	6574452
Pubmed	Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.	ERBB2 ERBB3	1.16e-06	2	38	2	16307437
Pubmed	Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.	ERBB2 ERBB3	1.16e-06	2	38	2	16168116
Pubmed	Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.	ERBB2 ERBB3	1.16e-06	2	38	2	26261492
Pubmed	Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy.	ERBB2 ERBB3	1.16e-06	2	38	2	29654069
Pubmed	Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus.	OXT AVP	1.16e-06	2	38	2	9678638
Pubmed	Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.	ERBB2 ERBB3	1.16e-06	2	38	2	29338072
Pubmed	Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin.	OXT AVP	1.16e-06	2	38	2	21960250
Pubmed	Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.	ERBB2 ERBB3	1.16e-06	2	38	2	24678002
Pubmed	Comparison of vasopressin and oxytocin expressions in the hypothalamo-neurohypophysial system of patients with chronic heart failure.	OXT AVP	1.16e-06	2	38	2	19672816
Pubmed	HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.	ERBB2 ERBB3	1.16e-06	2	38	2	19622585
Pubmed	Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies.	ERBB2 ERBB3	1.16e-06	2	38	2	26138066
Pubmed	Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.	ERBB2 ERBB3	1.16e-06	2	38	2	14614020
Pubmed	The protein tyrosine kinase family of the human genome.	EPHB4 ERBB2 ERBB3 TIE1	2.09e-06	83	38	4	11114734
Pubmed	Notch signaling is essential for ventricular chamber development.	EPHB4 ERBB2 ERBB3	3.46e-06	27	38	3	17336907
Pubmed	NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.	ERBB2 ERBB3	3.48e-06	3	38	2	26770651
Pubmed	EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.	ERBB2 ERBB3	3.48e-06	3	38	2	35902718
Pubmed	[Correlation of epidermal growth factor receptor mutations and HER2/3 protein expression with clinical outcome in advanced non-small cell lung cancer patients treated with gefitinib].	ERBB2 ERBB3	3.48e-06	3	38	2	20038315
Pubmed	Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.	ERBB2 ERBB3	3.48e-06	3	38	2	17426253
Pubmed	Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.	ERBB2 ERBB3	3.48e-06	3	38	2	27070783
Pubmed	HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLC.	ERBB2 ERBB3	3.48e-06	3	38	2	28656214
Pubmed	Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4).	ERBB2 ERBB3	3.48e-06	3	38	2	28653892
Pubmed	Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment.	ERBB2 ERBB3	3.48e-06	3	38	2	24346286
Pubmed	A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.	ERBB2 ERBB3	3.48e-06	3	38	2	18632642
Pubmed	Plasma concentrations of peptide hormones: Unrealistic levels of vasopressin (AVP), oxytocin (OXT), and brain natriuretic peptide (BNP).	OXT AVP	3.48e-06	3	38	2	39034759
Pubmed	Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.	ERBB2 ERBB3	3.48e-06	3	38	2	25471734
Pubmed	EGFR/ERBB receptors differentially modulate sebaceous lipogenesis.	ERBB2 ERBB3	3.48e-06	3	38	2	25889637
Interaction	FBLN2 interactions	ZNF696 LAMA5 LAMC2 ZNF865	7.12e-06	66	38	4	int:FBLN2
Interaction	SLA2 interactions	LAMC2 ERBB2 ERBB3	1.22e-05	24	38	3	int:SLA2
Cytoband	Xp22	PPEF1 EGFL6	1.98e-04	25	38	2	Xp22
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	ARSD PPEF1 EGFL6	1.17e-03	250	38	3	chrXp22
Cytoband	17p13.3	C1QBP ANKFY1	2.44e-03	88	38	2	17p13.3
Cytoband	17q12	ERBB2 SOCS7	3.08e-03	99	38	2	17q12
Cytoband	17q25.3	FAAP100 TMC6	3.20e-03	101	38	2	17q25.3
Cytoband	20p13	OXT AVP	3.26e-03	102	38	2	20p13
Cytoband	Ensembl 112 genes in cytogenetic band chr20p13	OXT AVP	4.70e-03	123	38	2	chr20p13
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	ERBB2 SOCS7	6.81e-03	149	38	2	chr17q12
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB2 ERBB3	1.39e-05	4	28	2	1096
GeneFamily	Laminin subunits	LAMA5 LAMC2	1.51e-04	12	28	2	626
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MEGF10 STAB1	7.93e-04	27	28	2	1253
GeneFamily	Fibronectin type III domain containing	EPHB4 TIE1 TNC	1.89e-03	160	28	3	555
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA5 CRELD1 LAMC2 SSPOP CRISPLD1 TNC SVEP1	1.02e-08	191	38	7	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA5 CRELD1 LAMC2 SSPOP CRISPLD1 TNC SVEP1	1.22e-08	196	38	7	M3008
Coexpression	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	EPHB4 FZD8 LAMA5 ERBB2 TIE1 STAB1	4.02e-08	135	38	6	M5825
Coexpression	NABA_CORE_MATRISOME	LAMA5 CRELD1 LAMC2 SSPOP CRISPLD1 TNC SVEP1	1.09e-07	270	38	7	MM17057
Coexpression	NABA_CORE_MATRISOME	LAMA5 CRELD1 LAMC2 SSPOP CRISPLD1 TNC SVEP1	1.24e-07	275	38	7	M5884
Coexpression	NABA_MATRISOME	LAMA5 CRELD1 LAMC2 SSPOP CRISPLD1 TNC SVEP1 MEGF10 EGFL6 WIF1	1.20e-06	1008	38	10	MM17056
Coexpression	NABA_MATRISOME	LAMA5 CRELD1 LAMC2 SSPOP CRISPLD1 TNC SVEP1 MEGF10 EGFL6 WIF1	1.41e-06	1026	38	10	M5889
Coexpression	RELA_DN.V1_DN	ECEL1 OXT CLCN1 AVP EGFL6	1.70e-06	139	38	5	M2695
Coexpression	NABA_MATRISOME_BLEO_FIBROTIC_LUNG	LAMA5 LAMC2 TNC	3.15e-06	20	38	3	MM17053
Coexpression	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	EPHB4 ERBB3 ARSD FAAP100 TMC6	4.25e-05	270	38	5	M19982
Coexpression	LIM_MAMMARY_STEM_CELL_UP	FZD8 TIE1 CRISPLD1 SVEP1 WIF1 PKD1	6.07e-05	479	38	6	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	FZD8 TIE1 CRISPLD1 SVEP1 WIF1 PKD1	6.35e-05	483	38	6	MM1082
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	KCNQ2 LAMC2 ERBB2 ERBB3 MYO16 SVEP1 TMC6 WIF1	1.26e-04	1074	38	8	M1941
Coexpression	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN	LAMA5 SERTAD4-AS1 AVP FAAP100	1.50e-04	186	38	4	M9510
Coexpression	GU_PDEF_TARGETS_UP	FZD8 LAMC2 TNC	1.50e-04	71	38	3	M3955
Coexpression	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	EPHB4 CRELD1 ERBB3 FCGBP PKD1	1.82e-04	368	38	5	M16431
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	EPHB4 TIE1 TNC STAB1	2.08e-05	91	38	4	GSM777059_100
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	EPHB4 TIE1 TNC STAB1	2.57e-05	96	38	4	GSM777063_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500	CRISPLD1 MEGF10 EGFL6 WIF1	3.39e-05	103	38	4	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000	CRISPLD1 TNC MEGF10 WIF1	1.36e-04	147	38	4	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000
ToppCell	AT1-AT2_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	KCNQ2 LAMC2 ECEL1 CRISPLD1 TNC	2.59e-07	162	38	5	57d627259d27f39885bf416d74bcb6656db6e27b
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LAMA5 ERBB2 ERBB3 ARSD TNC	7.36e-07	200	38	5	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FZD8 CRISPLD1 TNC SVEP1 WIF1	7.36e-07	200	38	5	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	ECEL1 OXT AVP PKD1	4.02e-06	126	38	4	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FZD8 ERBB3 TIE1 MYO16	8.67e-06	153	38	4	61fe71e32fc9c8cad875bc087aad0b0ff680bf45
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	LAMA5 FBXL17 ERBB3 WIF1	1.20e-05	166	38	4	89e2b8453180983533faccb4275867861876d7ee
ToppCell	wk_20-22-Mesenchymal-Chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FZD8 CRISPLD1 TNC WIF1	1.34e-05	171	38	4	d2938639e9a7c349e5a6ec61724222f9d127c89f
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FZD8 LAMA5 LAMC2 ERBB3	1.44e-05	174	38	4	2cd6638b361ca05ab83d09ce657194aed97873b7
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	FZD8 LAMA5 LAMC2 ERBB2	1.61e-05	179	38	4	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANKFY1 RAPGEF6 FCGBP TIE1	1.61e-05	179	38	4	06d412fc096d88de168969466ce422f0ab5553b2
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	LAMA5 LAMC2 ERBB2 ERBB3	1.61e-05	179	38	4	d5763912a4ce7188535675e338799b856edb9dda
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FZD8 ERBB3 ECEL1 MEGF10	1.68e-05	181	38	4	fad7ba168f541ac9d04edebc206f191e48bb7e99
ToppCell	wk_15-18-Epithelial-PNS-Early_Schwann\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	KCNQ2 ERBB3 ECEL1 MEGF10	1.75e-05	183	38	4	7e8366ec8117d36cec67f77dcb0e9a6032d87fcb
ToppCell	droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPEF1 TNC MEGF10 WIF1	1.75e-05	183	38	4	f55081068213cc1cdb2acad58ff10f6b48b44c72
ToppCell	droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 TIE1 CRISPLD1 STAB1	1.83e-05	185	38	4	eeb6f55a6f79adf80247baa2c4b0df44553557ad
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCNQ2 ERBB3 PPEF1 MEGF10	1.91e-05	187	38	4	dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA5 LAMC2 MYO16 WIF1	1.91e-05	187	38	4	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	LAMA5 LAMC2 ERBB3 MYO16	1.91e-05	187	38	4	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	IPF-Epithelial-Aberrant_Basaloid\|IPF / Disease state, Lineage and Cell class	LAMA5 LAMC2 ERBB3 TNC	1.91e-05	187	38	4	19d6a404fc3651d98a93e3848e372df51a239c57
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)\|368C / Donor, Lineage, Cell class and subclass (all cells)	FZD8 LAMA5 ERBB2 ERBB3	1.95e-05	188	38	4	9155b9a92496e75646778c025b02947e9e9ec73a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA5 LAMC2 MYO16 WIF1	1.95e-05	188	38	4	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	FZD8 LAMA5 ERBB2 ERBB3	1.95e-05	188	38	4	c74771584b3ba9561a99a54bf55a9203ddf8eff8
ToppCell	EC-Sinusoidal_ECs\|World / Lineage and Cell class	EPHB4 LAMA5 TIE1 STAB1	1.99e-05	189	38	4	9a0956c8a7069ba3bd0fa56d052d6e514453e578
ToppCell	IPF-Epithelial-Aberrant_Basaloid\|World / Disease state, Lineage and Cell class	LAMA5 LAMC2 ERBB3 TNC	1.99e-05	189	38	4	8030a353473da34ae92429f2d822171a2e94248f
ToppCell	wk_08-11-Epithelial-PNS-Schwann_precursor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KCNQ2 ERBB3 ECEL1 MEGF10	2.03e-05	190	38	4	4a777d8aa19cadd3b61b023772df142421a89113
ToppCell	LAM-Epithelial-AT1\|LAM / Condition, Lineage and Cell class	LAMA5 LAMC2 ERBB2 ERBB3	2.08e-05	191	38	4	66875b2ec2c510489407f3e433a90cdf74a15094
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 FZD8 TIE1 CRISPLD1	2.08e-05	191	38	4	c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SERTAD4-AS1 CRISPLD1 MEGF10 WIF1	2.08e-05	191	38	4	f9a46956778a8773d6656340ecf5d218376d79c2
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 FZD8 TIE1 CRISPLD1	2.08e-05	191	38	4	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 FZD8 TIE1 CRISPLD1	2.12e-05	192	38	4	1990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 FZD8 TIE1 CRISPLD1	2.12e-05	192	38	4	845cc9c18b4436b07dd3ce7980052683937546d2
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD1 TNC EGFL6 WIF1	2.12e-05	192	38	4	b35f0e422070ba9c7c1d9ff3eace4edc10286cde
ToppCell	EC\|World / Lineage and Cell class	EPHB4 LAMA5 TIE1 STAB1	2.12e-05	192	38	4	478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 FZD8 TIE1 CRISPLD1	2.12e-05	192	38	4	c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCell	normal_Lung-Epithelial_cells-AT1\|normal_Lung / Location, Cell class and cell subclass	LAMA5 LAMC2 ERBB2 ERBB3	2.25e-05	195	38	4	569d1ebc5a5aa110a2430b096755ae35354040c4
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB2 ERBB3 FCGBP SOCS7	2.25e-05	195	38	4	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAMA5 LAMC2 ERBB3 WIF1	2.25e-05	195	38	4	0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCell	(7)_Epithelial-I_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	LAMA5 LAMC2 ERBB2 ERBB3	2.30e-05	196	38	4	150554fa06868d29b0608189862eef6505ba757f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC2 CRISPLD1 MEGF10 WIF1	2.34e-05	197	38	4	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	EPHB4 LAMA5 SERTAD4-AS1 TIE1	2.34e-05	197	38	4	7caa2c86dc4d50b57a7db8f7278d1588282ad6db
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNC SVEP1 MEGF10 EGFL6	2.34e-05	197	38	4	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	EPHB4 LAMA5 SERTAD4-AS1 TIE1	2.34e-05	197	38	4	951f18f326967206adbbfc422cce9eea3d2e0854
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD1 TNC EGFL6 WIF1	2.34e-05	197	38	4	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TNC SVEP1 MEGF10 WIF1	2.34e-05	197	38	4	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	AT1-AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	LAMA5 LAMC2 ERBB2 ERBB3	2.39e-05	198	38	4	a5b3617ea2ed4bffba59edcf6284799c2b3bbb29
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB2 ERBB3 FCGBP OXT	2.39e-05	198	38	4	5dd2aa7684c36beffa204ca4c04d0501cabac10f
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMC2 ERBB3 TNC WIF1	2.39e-05	198	38	4	aed0476248e9637897eefb1623ec4035f2dacd82
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMC2 ERBB3 TNC WIF1	2.39e-05	198	38	4	691a2f1779225e5519155460eeb6a2aac5f67a92
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LAMC2 ERBB3 TNC WIF1	2.39e-05	198	38	4	e115eea04012e9e492e923ed080e1723c38d14fd
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LAMC2 ERBB3 TNC WIF1	2.39e-05	198	38	4	33d1e0b6f57663544bee0ffdde83a65da764d44c
ToppCell	Severe_COVID-19-Epithelial-AT1/AT2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	LAMC2 ERBB3 TNC WIF1	2.39e-05	198	38	4	43e33d28d9de5033bd00d39be953542a225236ed
ToppCell	wk_15-18-Epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAMA5 LAMC2 ERBB3 WIF1	2.39e-05	198	38	4	12bbe77c3d68bf1e545949dbb1eb49ed3641de3d
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CRISPLD1 MYO16 SVEP1 WIF1	2.39e-05	198	38	4	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	LAMA5 TNC EGFL6 WIF1	2.44e-05	199	38	4	d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCell	tumor_Lung-Epithelial_cells-tS2\|tumor_Lung / Location, Cell class and cell subclass	LAMC2 ERBB2 ERBB3 TNC	2.44e-05	199	38	4	28ec59e01061287fb0892491790b316e2b93e232
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA5 LAMC2 ERBB2 ERBB3	2.44e-05	199	38	4	aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ERBB2 ERBB3 MEGF10 WIF1	2.44e-05	199	38	4	3e35ee426ef06f9af568c37349b62dd1ee9b97ea
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISPLD1 TNC EGFL6 WIF1	2.44e-05	199	38	4	edd5300da1a3b758210ff8f949e9d1988b8bc7e2
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERBB2 ERBB3 MEGF10 WIF1	2.44e-05	199	38	4	f8846446ebbc4948cdc69640782db1358bbdc486
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ERBB2 ERBB3 MEGF10 WIF1	2.44e-05	199	38	4	fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LAMA5 LAMC2 ERBB2 ERBB3	2.48e-05	200	38	4	5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNC SVEP1 MEGF10 EGFL6	2.48e-05	200	38	4	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMA5 LAMC2 ERBB2 ERBB3	2.48e-05	200	38	4	c6f211bbadd0c9be776c58807249e06764df47dc
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	LAMA5 LAMC2 ERBB2 ERBB3	2.48e-05	200	38	4	e3a80626941363bfc9d97ef906d38c97080aecb1
ToppCell	Biopsy_Other_PF-Epithelial-Transitional_AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	LAMA5 LAMC2 ERBB3 WIF1	2.48e-05	200	38	4	1ba6327851aa61e9a1f1fe1671bc27929d93ac74
ToppCell	Biopsy_Other_PF-Epithelial\|Biopsy_Other_PF / Sample group, Lineage and Cell type	LAMC2 ERBB2 ERBB3 WIF1	2.48e-05	200	38	4	1ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ERBB3 FCGBP AVP	2.80e-05	69	38	3	3da27f504e82277fa4a8fb67d60fc26dee0a414f
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ECEL1 TNC MEGF10	8.75e-05	101	38	3	6523c314166dcf66c3ed13c02ca4b886b068e5b8
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ECEL1 TNC MEGF10	9.27e-05	103	38	3	d8965b338b90ddc0686ea0d94e9a330128566c39
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMA5 TNC MEGF10	1.32e-04	116	38	3	605bd4fdf547cc41783e99cd78425760ef6461ef
ToppCell	droplet-Skin-nan-18m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNC MYO16 SVEP1	1.53e-04	122	38	3	8f675dc341b3f6e22f7e52c34d167d9e37df0982
ToppCell	droplet-Skin-nan-18m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNC MYO16 SVEP1	1.53e-04	122	38	3	c7e81504e62d132624ec15b7d38dc5b6493a37a4
ToppCell	COVID-19_Mild-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CRISPLD1 MYO16 SVEP1	1.61e-04	124	38	3	5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4
ToppCell	droplet-Skin-nan-18m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNC MYO16 SVEP1	1.64e-04	125	38	3	5a309ce803d2b8efd791eb21808121bf5fc3ea8e
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KCNQ2 MYO16 SVEP1	1.64e-04	125	38	3	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CRISPLD1 MYO16 SVEP1	1.68e-04	126	38	3	6cb89754010d64875e115da6c5805efac7a4a82d
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CRISPLD1 MYO16 SVEP1	1.68e-04	126	38	3	69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso\|E18.5-samps / Age Group, Lineage, Cell class and subclass	LAMA5 LAMC2 ERBB3	2.39e-04	142	38	3	77fd145c1c500d580f70ac4e54c3fd879ecf0ab3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC SVEP1 WIF1	2.81e-04	150	38	3	7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC SVEP1 WIF1	2.81e-04	150	38	3	e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee
ToppCell	URO-Lymphocyte-T_NK-CD4_Naive\|URO / Disease, Lineage and Cell Type	OXT AVP MYO16	3.04e-04	154	38	3	6c214ad5cbbfa8bab3f76b593cb598dfb914b566
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ECEL1 PPEF1 PKD1	3.21e-04	157	38	3	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	AT1-AT2_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	LAMC2 ERBB3 MYO16	3.28e-04	158	38	3	3bc51cfd37b289cc3e866b54ce55a298e5eff690
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	LAMA5 FBXL17 STAB1	3.34e-04	159	38	3	24f87c666eff10c1844c900ffd7ad49fa9f80481
ToppCell	Club_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ERBB2 ERBB3 SOCS7	3.34e-04	159	38	3	a7bcff268b1962a561fd2848e01ae16565bce895
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA5 ERBB2 SOCS7	3.34e-04	159	38	3	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	NS-critical-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TIE1 MYO16 STAB1	3.40e-04	160	38	3	c61869d9dbba250270e59366e15af204e5b4395d
ToppCell	NS-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	OXT TIE1 MYO16	3.40e-04	160	38	3	8a4746463ca1976f7d6de803496c851249ced797
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC2 FCGBP TNC	3.52e-04	162	38	3	25323785dd33337bcefd05958a4a1a208a9ceb04
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC2 FCGBP TNC	3.52e-04	162	38	3	3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1
ToppCell	facs-Thymus-Epithelium-3m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC2 FCGBP TNC	3.52e-04	162	38	3	0a7138266054ea5954649c8b61ef93905d56b068
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	LAMA5 ERBB3 WIF1	3.52e-04	162	38	3	2259e9536147e9cdee772e3a30ba7d104573262c
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	FZD8 ERBB2 SVEP1	3.65e-04	164	38	3	d7053de88ef8e42cac6726a40e72f212659ee034
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB3 PPEF1 MEGF10	3.65e-04	164	38	3	57301178e420983c0cb72178e288a3a0449fdda3
ToppCell	10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	C1QBP TIE1 AVP	3.65e-04	164	38	3	47355439e578d1b1a387fb4ee761162028abea4a
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC2 ERBB3 MYO16	3.78e-04	166	38	3	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC2 ERBB3 MYO16	3.78e-04	166	38	3	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	wk_20-22-Epithelial-Airway_epithelial_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LAMA5 ERBB3 WIF1	3.78e-04	166	38	3	fcd0bd70b553789092249806ace324b77bd10481
ToppCell	wk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LAMA5 ERBB3 WIF1	3.78e-04	166	38	3	b60954e5625743657d0fd9264b738b46e72fd8a6
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ERBB3 ECEL1 MEGF10	3.85e-04	167	38	3	49b19159c62d33d65ed1e59a148c11ae902fd41c
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; HL60; HT_HG-U133A	ZNF696 ERBB2 ANKFY1 FAAP100 SVEP1 SOCS7	9.04e-07	199	38	6	2198_UP
Drug	Demoxytocin	OXT AVP	2.71e-06	2	38	2	CID000008229
Drug	AC1NURZQ	OXT AVP	2.71e-06	2	38	2	CID005490952
Drug	P9-28	OXT AVP	2.71e-06	2	38	2	CID000139428
Drug	Pro-arg-gly-amide	OXT AVP	2.71e-06	2	38	2	CID000170777
Drug	2-phenylalanine	OXT AVP	2.71e-06	2	38	2	CID000031722
Drug	Phasvatocin	OXT AVP	2.71e-06	2	38	2	CID000192334
Drug	ethyl cyclohexylideneacetate	OXT AVP	2.71e-06	2	38	2	CID000073776
Drug	Cgp 29325	OXT AVP	2.71e-06	2	38	2	CID000175772
Drug	Glumitocin	OXT AVP	2.71e-06	2	38	2	CID003084054
Drug	colchine	LAMA5 LAMC2 ECEL1 OXT AVP TNC PKD1	2.91e-06	383	38	7	CID000002833
Drug	AC1O4Q3H	OXT AVP	8.13e-06	3	38	2	CID006410744
Drug	2-acetamidoethanethiol	ERBB2 ERBB3	8.13e-06	3	38	2	ctd:C023704
Drug	ranatensin C	OXT AVP	8.13e-06	3	38	2	CID005488559
Drug	Annetocin	OXT AVP	8.13e-06	3	38	2	CID000197651
Drug	L 366811	OXT AVP	8.13e-06	3	38	2	CID003083084
Drug	dE-Vvt	OXT AVP	8.13e-06	3	38	2	CID003083171
Drug	AC1L45X9	OXT AVP	8.13e-06	3	38	2	CID000151233
Drug	L 366682	OXT AVP	8.13e-06	3	38	2	CID000196819
Drug	D-3250	ERBB2 AVP	8.13e-06	3	38	2	CID004124837
Drug	Dglvp	OXT AVP	8.13e-06	3	38	2	CID000169434
Drug	Asvatocin	OXT AVP	8.13e-06	3	38	2	CID000192333
Drug	Sikvav	LAMA5 LAMC2 TNC	8.47e-06	24	38	3	CID005487517
Drug	NSC 714187	LAMA5 LAMC2 ERBB3 PPEF1	1.21e-05	85	38	4	CID005288693
Drug	Phenypressin	OXT AVP	1.62e-05	4	38	2	CID003082314
Drug	Pressinamide	OXT AVP	1.62e-05	4	38	2	CID003082272
Drug	Dpvdavp	OXT AVP	1.62e-05	4	38	2	CID003081540
Drug	Vasotocin	OXT AVP	1.62e-05	4	38	2	ctd:D014668
Drug	Z-PLG	OXT AVP	1.62e-05	4	38	2	CID000151917
Drug	Conopressin G	OXT AVP	1.62e-05	4	38	2	CID000163847
Drug	Mpomeovt	OXT AVP	2.70e-05	5	38	2	CID000122244
Drug	Tgot	OXT AVP	2.70e-05	5	38	2	CID003082106
Drug	AGN 190851	OXT AVP	2.70e-05	5	38	2	CID000131829
Drug	L 365209	OXT AVP	2.70e-05	5	38	2	CID000196774
Drug	Felypressin	OXT AVP	2.70e-05	5	38	2	CID000005956
Drug	Mifepristone	LAMA5 LAMC2 ERBB3 OXT TNC SVEP1 WIF1	3.15e-05	553	38	7	ctd:D015735
Drug	B-Ms	LAMA5 LAMC2 ERBB2 TNC	3.86e-05	114	38	4	CID000445091
Drug	L-366,509	OXT AVP	4.05e-05	6	38	2	CID003083288
Drug	5-methoxy-N-isobutanoyltryptamine	OXT AVP	4.05e-05	6	38	2	CID006455231
Drug	L-371,257	OXT AVP	4.05e-05	6	38	2	CID006918320
Drug	D3PVP	OXT AVP	4.05e-05	6	38	2	CID000195824
Drug	oxypressin	OXT AVP	4.05e-05	6	38	2	CID000164712
Drug	ZD-6	ERBB2 ERBB3	4.05e-05	6	38	2	CID010062753
Drug	Deavp	OXT AVP	4.05e-05	6	38	2	CID000114715
Drug	IEM-611	OXT AVP	5.67e-05	7	38	2	CID000039794
Drug	B3852	OXT AVP	5.67e-05	7	38	2	CID000086074
Drug	Vdavp	OXT AVP	5.67e-05	7	38	2	CID000171113
Drug	imatinib	EPHB4 FZD8 ERBB2 ERBB3 TIE1 AVP	7.25e-05	430	38	6	CID000005291
Drug	isovaleramide	KCNQ2 AVP	7.55e-05	8	38	2	CID000010930
Drug	L 366948	OXT AVP	7.55e-05	8	38	2	CID000188397
Drug	Folfox protocol	ERBB2 ERBB3	7.55e-05	8	38	2	ctd:C410216
Drug	CI-1033	EPHB4 ERBB2 ERBB3	9.49e-05	53	38	3	CID000156413
Drug	Cp 14	OXT AVP	9.69e-05	9	38	2	CID005487244
Drug	AC1MIZWH	OXT AVP	9.69e-05	9	38	2	CID003083001
Drug	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid	OXT AVP	9.69e-05	9	38	2	ctd:C077792
Drug	d(CH2)5-Davp	OXT AVP	9.69e-05	9	38	2	CID000123750
Drug	Mcp-tva-argipressin	OXT AVP	9.69e-05	9	38	2	CID000122322
Drug	Hydrin 1	OXT AVP	9.69e-05	9	38	2	CID000195374
Drug	A-state	ERBB2 TNC	9.69e-05	9	38	2	CID005460479
Drug	LMWH	LAMA5 KCNQ2 LAMC2 ERBB3 OXT AVP TNC	9.89e-05	663	38	7	CID000000772
Drug	AC1L3JHX	C1QBP ERBB2 ERBB3 PKD1	1.01e-04	146	38	4	CID000090206
Drug	kalinin	LAMA5 LAMC2 TNC	1.06e-04	55	38	3	CID000032518
Drug	Bay K 8644	ECEL1 OXT AVP PKD1	1.12e-04	150	38	4	CID000002303
Drug	Duratocin	OXT AVP	1.21e-04	10	38	2	CID000071715
Drug	JTP 4819	OXT AVP	1.21e-04	10	38	2	ctd:C094211
Drug	6-(methylamino)pyrido(3,4-d)pyrimidine	ERBB2 ERBB3	1.21e-04	10	38	2	ctd:C107875
Drug	cyclo(Leu-Gly)	OXT AVP	1.21e-04	10	38	2	CID000002902
Drug	AC1MIWZV	OXT AVP	1.21e-04	10	38	2	CID003081474
Drug	AC1L9INI	LAMA5 LAMC2 TNC	1.31e-04	59	38	3	CID000445839
Drug	LG 5	LAMA5 LAMC2 ERBB3	1.37e-04	60	38	3	CID011840957
Drug	AC1L1G72	LAMA5 LAMC2	1.48e-04	11	38	2	CID000003553
Drug	BE-23372M	ERBB2 ERBB3	1.48e-04	11	38	2	CID005311105
Drug	BM165	LAMA5 LAMC2	1.48e-04	11	38	2	CID003352881
Drug	Dpmetyravp	OXT AVP	1.48e-04	11	38	2	CID000119517
Drug	1-adamantaneacetic acid	OXT AVP	1.77e-04	12	38	2	CID000123221
Drug	sulmazole	ECEL1 TNC	1.77e-04	12	38	2	CID000005353
Drug	P-14	C1QBP ERBB2 TMC6 WIF1	1.90e-04	172	38	4	CID000017957
Drug	CMF regimen	ERBB2 ERBB3	2.09e-04	13	38	2	ctd:C034456
Drug	AC1MIYR4	OXT AVP	2.09e-04	13	38	2	CID003082393
Drug	2-thiazolylethylamine	OXT AVP	2.44e-04	14	38	2	CID000087653
Drug	Ovta	OXT AVP	2.44e-04	14	38	2	CID003081047
Drug	AC1NFF1B	OXT AVP	2.44e-04	14	38	2	CID004657542
Drug	Utedrin	OXT AVP	2.44e-04	14	38	2	CID000005771
Drug	A0395	LAMA5 LAMC2 ERBB2	2.67e-04	75	38	3	CID009906466
Drug	Cloralosa	OXT AVP TNC	2.77e-04	76	38	3	CID000027525
Drug	NVP-TAE684	ERBB2 ERBB3	2.81e-04	15	38	2	ctd:C516714
Drug	2-amino-5-methylpyridine	LAMA5 LAMC2 ERBB3	2.88e-04	77	38	3	CID000015348
Drug	Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A	ANKFY1 ARSD SVEP1 EGFL6	2.95e-04	193	38	4	3880_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A	EPHB4 ZNF696 LAMA5 FAAP100	3.01e-04	194	38	4	1223_DN
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	LAMC2 ECEL1 CLCN1 SOCS7	3.07e-04	195	38	4	4424_UP
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	EPHB4 SOCS7 WIF1 STAB1	3.07e-04	195	38	4	3800_UP
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A	LAMC2 ERBB2 ERBB3 TNC	3.07e-04	195	38	4	2152_UP
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A	CRELD1 LAMC2 ANKFY1 TNC	3.13e-04	196	38	4	5069_DN
Drug	Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A	LAMC2 ANKFY1 SVEP1 SOCS7	3.13e-04	196	38	4	4409_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	EPHB4 ZNF696 FAAP100 TNC	3.13e-04	196	38	4	3144_UP
Drug	Budesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	EPHB4 FZD8 ZXDC ERBB2	3.13e-04	196	38	4	6330_DN
Drug	Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A	ZXDC LAMC2 ARSD TMC6	3.19e-04	197	38	4	5106_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ZNF696 LAMC2 ERBB3 STAB1	3.19e-04	197	38	4	2328_UP
Drug	3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A	LAMC2 PPEF1 SVEP1 EGFL6	3.19e-04	197	38	4	3382_UP
Drug	benzanilide	KCNQ2 AVP	3.21e-04	16	38	2	CID000007168
Disease	Dysmenorrhea	OXT AVP	1.61e-06	2	38	2	C0013390
Disease	Hyponatremia	OXT AVP	9.67e-06	4	38	2	C0020625
Disease	Polyuria	OXT AVP	1.61e-05	5	38	2	C0032617
Disease	oxytocin-neurophysin 1 measurement	OXT AVP	2.41e-05	6	38	2	EFO_0802839
Disease	Head and Neck Carcinoma	ERBB2 ERBB3	7.22e-05	10	38	2	C3887461
Disease	cystic kidney disease (implicated_via_orthology)	EPHB4 LAMA5	7.22e-05	10	38	2	DOID:2975 (implicated_via_orthology)
Disease	gallbladder neoplasm	ERBB2 ERBB3	8.82e-05	11	38	2	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB2 ERBB3	8.82e-05	11	38	2	C0153452
Disease	Schizophrenia	KCNQ2 ERBB3 RAPGEF6 OXT AVP MYO16 MEGF10	1.18e-04	883	38	7	C0036341
Disease	median neuropathy (biomarker_via_orthology)	ERBB2 ERBB3	1.46e-04	14	38	2	DOID:571 (biomarker_via_orthology)
Disease	Benign neoplasm of stomach	ERBB2 ERBB3	2.17e-04	17	38	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ERBB2 ERBB3	2.17e-04	17	38	2	C0496905
Disease	Carcinoma in situ of stomach	ERBB2 ERBB3	2.17e-04	17	38	2	C0154060
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 ERBB3	2.72e-04	19	38	2	DOID:2876 (is_marker_for)
Disease	Stomach Carcinoma	ERBB2 ERBB3	3.34e-04	21	38	2	C0699791
Disease	urinary bladder cancer (is_marker_for)	ERBB2 ERBB3 WIF1	3.57e-04	107	38	3	DOID:11054 (is_marker_for)
Disease	Nasopharyngeal carcinoma	ERBB2 ERBB3	3.67e-04	22	38	2	C2931822
Disease	stomach carcinoma (is_marker_for)	ERBB2 ERBB3	4.38e-04	24	38	2	DOID:5517 (is_marker_for)
Disease	Stomach Neoplasms	ERBB2 ERBB3 FCGBP WIF1	5.67e-04	297	38	4	C0038356
Disease	Malignant neoplasm of stomach	ERBB2 ERBB3 FCGBP WIF1	5.89e-04	300	38	4	C0024623
Disease	Ischemia	OXT AVP	5.98e-04	28	38	2	C0022116
Disease	Carcinoma, Ovarian Epithelial	ERBB2 SOCS7	6.87e-04	30	38	2	C4721610
Disease	intestinal cancer (implicated_via_orthology)	ERBB2 ERBB3	7.82e-04	32	38	2	DOID:10155 (implicated_via_orthology)
Disease	Head and Neck Neoplasms	ERBB2 ERBB3	8.31e-04	33	38	2	C0018671
Disease	nephroblastoma (is_marker_for)	ERBB2 WIF1	8.83e-04	34	38	2	DOID:2154 (is_marker_for)
Disease	ductal carcinoma in situ (is_marker_for)	ERBB2 ERBB3	1.16e-03	39	38	2	DOID:0060074 (is_marker_for)
Disease	Disease Exacerbation	LAMC2 ERBB2 ERBB3	1.25e-03	165	38	3	C0235874

Protein segments in the cluster

Peptide	Gene	Start	Entry
AGGCARCKGPLPTDC	ERBB2	221	P04626
EPCGGLCPKACEGTG	ERBB3	321	P21860
GAGACYGRGVCPCSG	ARSD	491	P51689
FGECVGPNKCRCFPG	EGFL6	71	Q8IUX8
PGLLRPRGPCACGCG	C1QBP	56	Q07021
GCDATCWGPGPGGCL	ANKFY1	711	Q9P2R3
GTVCGQPCPEGRFGK	MEGF10	261	Q96KG7
CMGAGPGRCKKCSPG	CRELD1	281	Q96HD1
CRECRPGGSCAPCGG	EPHB4	361	P54760
KCCLPDDGGPGAGSF	MYO16	1436	Q9Y6X6
SKGSPCRGPLCGCCP	KCNQ2	416	O43526
FDGCGGCRPCACGPA	LAMA5	2061	O15230
YCLPGPVLCAACGGG	FAAP100	341	Q0VG06
GGGACPEGCPERKAF	ECEL1	91	O95672
PGGGAAPCEPGCQCR	FZD8	221	Q9H461
GGAQGCGECVSKPCP	FCGBP	3436	Q9Y6R7
SKGCGEGCGPQGCPV	FCGBP	5021	Q9Y6R7
GRPCSACPPSFGGGC	CRISPLD1	221	Q9H336
ACTPCKQPRCGGGGC	FBXL17	206	Q9UF56
GGSKGGCGSSCCVPV	KRTAP5-3	81	Q6L8H2
RSDGTCVCKPGFGGP	LAMC2	586	Q13753
PGRGCGPCEPPCLCG	PKD1	26	P98161
GKNGCFPNTCRGGGC	PPEF1	366	O14829
PPCSFGKQFGGKRGC	RAPGEF6	91	Q8TEU7
GFCAPGCTCPPGLFL	SSPOP	2921	A2VEC9
PPPAARLCCLGGGCG	SERTAD4-AS1	86	Q5TG53
CLPCGPGGKGRCFGP	OXT	41	P01178
PGGKGRCFGPNICCA	OXT	46	P01178
VGGFLCKCPPGFLGT	SVEP1	1326	Q4LDE5
CAVGVGCCFGTPLGG	CLCN1	271	P35523
PGKTFCCGICGRGFG	ZNF865	546	P0CJ78
RPFGCPVGGCGKKFT	ZXDC	236	Q2QGD7
GPGCTKECPGCLHGG	TIE1	221	P35590
CLPCGPGGKGRCFGP	AVP	41	P01185
PGGKGRCFGPSICCA	AVP	46	P01185
GCGCVCEPGWKGPNC	TNC	171	P24821
GGGSWKGRPFPCGAC	ZNF696	116	Q9H7X3
CKGFFGPDCTQCPGG	STAB1	721	Q9NY15
CPGFFGTLCEPCPGG	STAB1	1321	Q9NY15
GTLCEPCPGGLGGVC	STAB1	1326	Q9NY15
GGLCVTPGFCICPPG	WIF1	221	Q9Y5W5
PGVKTVGGGCCPCPC	SOCS7	71	O14512
GQPGSGGVCSCCGRL	TMC6	191	Q7Z403